Skip to main content

Advertisement

SpringerLink
Log in

Advances in the Management of Chronic Thromboembolic Pulmonary Hypertension

  • Pulmonary Hypertension (J Klinger, Section Editor)
  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH), a potentially curable form of pulmonary hypertension with pulmonary thromboendarterectomy surgery, has been the focus of significant medical advances. In addition to new imaging modalities that are now used to help recognize and diagnose CTEPH, additional treatment options have emerged for inoperable cases. These include a newly approved medical therapy for inoperable disease or persistent/recurrent CTEPH as well as percutaneous balloon angioplasty of the pulmonary arteries. In this article, we summarize these recent advances in the field and review the related literature.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Pengo V, Lensing AW, Prins MH, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 2004;350:2257–64. Seminal prospective study that examined the incidence of chronic thromboembolic pulmonary hypertension in patients with acute pulmonary embolus and without prior history of venous thromboembolism.

  2. Guerin L, Couturaud F, Parent F, et al. Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Prevalence of CTEPH after pulmonary embolism. Thromb Haemost. 2014;112:598–605. Prospective study examining the prevalence of chronic thromboembolic pulmonary hypertension during a median of 26 months after an acute pulmonary embolus.

  3. McLaughlin VV, Langer A, Tan M, et al. Contemporary trends in the diagnosis and management of pulmonary arterial hypertension: an initiative to close the care gap. Chest. 2013;143:324–32. Large study that compared reported clinical practice in pulmonary arterial hypertension patients to published guidelines by the American College of Chest Physicians using an electronic data management system.

  4. Pepke-Zaba J, Delcroix M, Lang I, et al. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation. 2011;124:1973–81. Study examining clinical characteristics and management data of chronic thromboembolic pulmonary hypertension patients using a large international registry.

  5. Tunariu N, Gibbs SJ, Win Z, et al. Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension. J Nucl Med. 2007;48:680–4. Classic study showing increased sensitivity of ventilation perfusion scitnigrahy compared to CT-pulmonary angiography in the screening of patients with suspected chronic thromboembolic pulmonary hypertension.

  6. Clements PJ, Tan M, McLaughlin VV, et al. The pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAH. Ann Rheum Dis. 2012;71:249–52.

    Article  CAS  PubMed  Google Scholar 

  7. Freeman LM. Don’t bury the V/Q scan: it’s as good as multidetector CT angiograms with a lot less radiation exposure. J Nucl Med. 2008;49:5–8.

  8. Bergin CJ, Sirlin CB, Hauschildt JP, et al. Chronic thromboembolism: diagnosis with helical CT and MR imaging with angiographic and surgical correlation. Radiology. 1997;204:695–702.

    Article  CAS  PubMed  Google Scholar 

  9. Kim NH, Delcroix M, Jenkins DP, et al. Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol. 2013;62:D92–9. Recent review summarizing the conclusions of the chronic thromboembolic pulmonary hypertension task force and meeting discussions from the 5th World Symposium on Pulmonary Hypertension.

  10. He J, Fang W, Lv B, et al. Diagnosis of chronic thromboembolic pulmonary hypertension: comparison of ventilation/perfusion scanning and multidetector computed tomography pulmonary angiography with pulmonary angiography. Nucl Med Commun. 2012;33:459–63.

    Article  PubMed  Google Scholar 

  11. Rajaram S, Swift AJ, Telfer A, et al. 3D contrast-enhanced lung perfusion MRI is an effective screening tool for chronic thromboembolic pulmonary hypertension: results from the ASPIRE Registry. Thorax. 2013;68:677–8.

    Article  PubMed  Google Scholar 

  12. Ley S, Ley-Zaporozhan J, Pitton MB, et al. Diagnostic performance of state-of-the-art imaging techniques for morphological assessment of vascular abnormalities in patients with chronic thromboembolic pulmonary hypertension (CTEPH). Eur Radiol. 2012;22:607–16.

    Article  PubMed  Google Scholar 

  13. Liu M, Ma Z, Guo X, Zhang H, Yang Y, Wang C. Computed tomographic pulmonary angiography in the assessment of severity of chronic thromboembolic pulmonary hypertension and right ventricular dysfunction. Eur J Radiol. 2011;80:e462–9.

    Article  PubMed  Google Scholar 

  14. Sugiura T, Tanabe N, Matsuura Y, et al. Role of 320-slice CT imaging in the diagnostic workup of patients with chronic thromboembolic pulmonary hypertension. Chest. 2013;143:1070–7.

    Article  PubMed  Google Scholar 

  15. Reichelt A, Hoeper MM, Galanski M, Keberle M. Chronic thromboembolic pulmonary hypertension: evaluation with 64-detector row CT versus digital substraction angiography. Eur J Radiol. 2009;71:49–54.

    Article  PubMed  Google Scholar 

  16. Hoey ET, Mirsadraee S, Pepke-Zaba J, Jenkins DP, Gopalan D, Screaton NJ. Dual-energy CT angiography for assessment of regional pulmonary perfusion in patients with chronic thromboembolic pulmonary hypertension: initial experience. AJR Am J Roentgenol. 2011;196:524–32.

    Article  PubMed  Google Scholar 

  17. Rossi A, Attina D, Borgonovi A, et al. Evaluation of mosaic pattern areas in HRCT with Min-IP reconstructions in patients with pulmonary hypertension: could this evaluation replace lung perfusion scintigraphy? Eur J Radiol. 2012;81:e1–6.

    Article  CAS  PubMed  Google Scholar 

  18. Hurdman J, Condliffe R, Elliot CA, et al. ASPIRE registry: Assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre. Eur Respir J. 2012;39:945–55.

  19. Rajaram S, Swift AJ, Capener D, et al. Diagnostic accuracy of contrast-enhanced MR angiography and unenhanced proton MR imaging compared with CT pulmonary angiography in chronic thromboembolic pulmonary hypertension. Eur Radiol. 2012;22:310–7.

    Article  PubMed  Google Scholar 

  20. Sugiyama M, Fukuda T, Sanda Y, et al. Organized thrombus in pulmonary arteries in patients with chronic thromboembolic pulmonary hypertension; imaging with cone beam computed tomography. Jpn J Radiol. 2014;32:375–82.

    Article  PubMed  Google Scholar 

  21. Auger WR, Kim NH, Trow TK. Chronic thromboembolic pulmonary hypertension. Clin Chest Med. 2010;31:741–58.

    Article  PubMed  Google Scholar 

  22. Condliffe R, Kiely DG, Gibbs JS, et al. Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med. 2008;177:1122–7.

    Article  PubMed  Google Scholar 

  23. Olschewski H, Simonneau G, Galiè N, et al. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med. 2002;347:322–9.

  24. Suntharalingam J, Treacy CM, Doughty NJ, et al. Long-term use of sildenafil in inoperable chronic thromboembolic pulmonary hypertension. Chest. 2008;134:229–36.

    Article  CAS  PubMed  Google Scholar 

  25. Jaïs X, D’Armini AM, Jansa P, et al. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronic Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial. J Am Coll Cardiol. 2008;52:2127–34. Seminal randomized control trial showing no significant improvement in outcomes in patients with chronic thromboembolic pulmonary hypertension when the endothelin receptor antagonist bosentan was compared to placebo.

  26. Ghofrani HA, D’Armini AM, Grimminger F, et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med. 2013;369:319–29. Seminal randomized control trial showing a significant improvement in outcomes in patients with chronic thromboembolic pulmonary hypertension when the soluble guanylate cyclace stimulator riociguat was compared to placebo.

  27. Simonneau G, D’Armini AM, Ghofrani HA, et al. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2). Eur Respir J. 2015;45:1293–302.

  28. Jensen KW, Kerr KM, Fedullo PF, et al. Pulmonary hypertensive medical therapy in chronic thromboembolic pulmonary hypertension before pulmonary thromboendarterectomy. Circulation. 2009;120:1248–54.

    Article  PubMed  Google Scholar 

  29. Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62:D34–41.

    Article  PubMed  Google Scholar 

  30. Mo M, Kapelanski DP, Mitruka SN. Reoperative pulmonary thomboendarterectomy. Ann Thorac Surg. 1999;68:1770–7.

  31. Voorburg JA, Cats VM, Buis B, Bruschke AV. Balloon angioplasty in the treatment of pulmonary hypertension caused by pulmonary embolism. Chest. 1988;94:1249–53.

    Article  CAS  PubMed  Google Scholar 

  32. Feinstein JA, Goldhaber SZ, Lock JE, Ferndandes SM, Landzberg MJ. Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension. Circ J. 2001;103:10–3. The first larger case series describing the use of balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension in lieu of surgery.

  33. Pitton MB, Herber S, Mayer E, Thelen M. Pulmonary balloon angioplasty of chronic thromboembolic pulmonary hypertension (CTEPH) in surgically inaccessible cases. RoFo. 2003;175:631–4.

  34. Sugimura K, Fukumoto Y, Satoh K, et al. Percutaneous transluminal pulmonary angioplasty markedly improves pulmonary hemodynamics and long-term prognosis in patients with chronic thromboembolic pulmonary hypertension. Circ J. 2012;76:485–8. Recent case series of balloon pulmonary angioplasty with the help of optical coherence tomography in patients with more distal chronic thromboembolic pulmonary hypertension.

  35. Kataoka M, Inami T, Hayashida K, et al. Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv. 2012;5:756–62. Recent case series of balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension that also showed a correlation between worse clinical presentation and/or hemodynamics and post-procedure reperfusion pulmonary edema.

  36. Mizoguchi H, Ogawa A, Munemasa M, Mikouchi H, Ito H, Matsubara H. Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv. 2012;5:748–55. Largest case series to date, reporting on the use of balloon pulmonary angioplasty in the treatment of chronic thromboembolic pulmonary hypertension using itnravascular utlrasonographic guidance and with a follow up of more than 2 years.

  37. Yoshimi S, Tanabe N, Masuda M, et al. Survival and quality of life for patients with peripheral type chronic thromboembolic pulmonary hypertension. Circ J. 2008;72:958–65.

  38. Andreassen AK, Ragnarsson A, Gude E, Geiran O, Andersen R. Balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension. Heart. 2013;99:1415–20. Smaller case series on the use of balloon pulmonary angioplasty in chronic thromboembolic pulmonray hypertension with a relatively high mortality rate.

  39. Fukui S, Ogo T, Morita Y, et al. Right ventricular reverse remodelling after balloon pulmonary angioplasty. Eur Respir J. 2014;43:1394–402.

  40. Taniguchi Y, Miyagawa K, Nakayama K, et al. Balloon pulmonary angioplasty: an additional treatment option to improve the prognosis of patients with chronic thromboembolic pulmonary hypertension. EuroIntervention. 2014;10:518–25. Retrospective study comparing outcomes in chronic thromboembolic pulmonary hypertension patients treated with either pulmonary thromboendarterectomy or balloon pulmonary angioplasty.

  41. Archibald CJ, Auger WR, Fedullo PF, et al. Long-term outcome after pulmonary thromboendarterectomy. Am J Respir Crit Care Med. 1999;160:523–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to thank Dr. Deepa Gopalan for providing the images for this manuscript.

Compliance with Ethics Guidelines

ᅟ

Conflict of Interest

Dr. Papamatheakis has received speaking honoraria by Actelion Pharmaceuticals. Dr Kim has received consultancy and speaking honoraria from Actelion Pharmaceuticals and Bayer HealthCare.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Division of Pulmonary and Critical Care Medicine, University of California San Diego, 9300 Campus Point Dr. MC 7381, La Jolla, CA, 92037, USA

    Demosthenes G. Papamatheakis & Nick H. Kim

Authors
  1. Demosthenes G. Papamatheakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nick H. Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nick H. Kim.

Additional information

This article is part of the Topical Collection on Pulmonary Hypertension

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Papamatheakis, D.G., Kim, N.H. Advances in the Management of Chronic Thromboembolic Pulmonary Hypertension. Curr Hypertens Rep 17, 75 (2015). https://doi.org/10.1007/s11906-015-0582-9

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11906-015-0582-9

Keywords

Search

Navigation